octreotid insulin-lik growth factor level acromegali insulin-lik growth factor igf circul complex state sever protein bp hormon nutrit factor somatostatin analogu octreotid hypersomaototrop acromegali level ria acromegal patient serum hormon sampl hr period octreotid respond mean pre-treat basal GH level micrograms/l micrograms/l micrograms/l month octreotid treatment acut subcutan inject microgram GH microgram/l control micrograms/l control hr level micrograms/l control time period signific increas level hr baselin hr inject insulin suppressor time non-respond mean level micrograms/l hr octreotid administr micrograms/l octreotid dynam invers relationship GH level absenc chang octreotid non-respond non-suppress insulin octreotid respons patient direct gh-mediat mechan regul octreotid patient acromegali use marker respons acromegali treatment patient clinic benefit equivoc GH attenu 